Michael Roller
Patrimonio netto: 650 957 $ in data 31/07/2026
Patrimonio netto: 650 957 $ in data 31/07/2026
Michael Roy David Roller currently works at Circassia Ltd., as Director from 2020 and The Institute of Chartered Accountants in England & Wales, as Member.
Mr. Roller also formerly worked at Filtronic Plc, as Senior Independent Non-Executive Director, Capital Consulting Ltd., as Finance Director, Bioquell Ltd., as Group Finance Director & Executive Director from 2014 to 2019, Corin Group Ltd., as Finance Director, Secretary & Director from 2010 to 2012, Strathdon Investments Ltd., as Finance Director, Prosonix Ltd., as Director, Bioquell UK Ltd., as Director, Genus Plc, as Group Finance Director in 2003, and Niox Group Plc, as Chief Financial Officer & Executive Director.
Mr. Roller received his undergraduate degree from Merton College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
NIOX GROUP PLC 0,19% | 01/04/2025 | 800.852 ( 0,19% ) | 650 957 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
NIOX Healthcare Ltd.
NIOX Healthcare Ltd. Pharmaceuticals: OtherHealth Technology Develops medicines for allergic and auto-immune diseases | Direttore/Membro del Consiglio | 09/01/2020 |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Operates as a membership organization for chartered accountant firm and students | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
| NIOX GROUP PLC | Direttore Finanziario/CFO | 14/05/2025 |
Bioquell UK Ltd.
Bioquell UK Ltd. Industrial MachineryProducer Manufacturing Manufacturers special industry machines | Direttore/Membro del Consiglio | 20/05/2019 |
| BIOQUELL PLC | Direttore Finanziario/CFO | 01/05/2019 |
| CORIN GROUP PLC | Direttore Finanziario/CFO | 01/06/2012 |
Strathdon Investments Ltd.
Strathdon Investments Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Direttore Finanziario/CFO | 30/08/2007 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Filtronic Plc
Filtronic Plc Telecommunications EquipmentElectronic Technology Designs, manufactures and supplies RF communications products | Electronic Technology |
NIOX Healthcare Ltd.
NIOX Healthcare Ltd. Pharmaceuticals: OtherHealth Technology Develops medicines for allergic and auto-immune diseases | Health Technology |
Capital Consulting Ltd.
Capital Consulting Ltd. Miscellaneous Commercial ServicesCommercial Services Provides recruitment outsourcing services | Commercial Services |
Bioquell Ltd.
Bioquell Ltd. MiscellaneousMiscellaneous Operates as an investment holding company with interest in bio-decontamination and containment equipment | Miscellaneous |
Corin Group Ltd.
Corin Group Ltd. Medical SpecialtiesHealth Technology Designs and manufactures orthopedic devices | Health Technology |
Strathdon Investments Ltd.
Strathdon Investments Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Genus Plc
Genus Plc Agricultural Commodities/MillingProcess Industries Provides genetic livestock services to produce high-quality meat and milk | Process Industries |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Operates as a membership organization for chartered accountant firm and students | Commercial Services |
Prosonix Ltd.
Prosonix Ltd. Pharmaceuticals: MajorHealth Technology Develops a portfolio of inhaled respiratory medicines | Health Technology |
Bioquell UK Ltd.
Bioquell UK Ltd. Industrial MachineryProducer Manufacturing Manufacturers special industry machines | Producer Manufacturing |
Merton College
Merton College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Niox Group Plc
Niox Group Plc Medical/Nursing ServicesHealth Services Develops immuno therapies to control immune system responses | Health Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale